UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement

PloS one, 2015-06, Vol.10 (6), p.e0120299-e0120299

2015

Volltextzugriff (PDF)

Multicentre study and systematic review: Allopurinol exposure during pregnancy

Alimentary pharmacology & therapeutics, 2024-08, Vol.60 (4), p.503-518

2024

Volltextzugriff (PDF)

Exploring the role of oxidative stress and the effect of N‐acetylcysteine in thiopurine‐induced liver injury in inflammatory bowel disease: A randomized crossover pilot study

Basic & clinical pharmacology & toxicology, 2024-04, Vol.134 (4), p.507-518

2024

Volltextzugriff (PDF)

Therapeutic drug monitoring of methotrexate in patients with Crohn's disease

Alimentary pharmacology & therapeutics, 2023-12, Vol.58 (11-12), p.1151-1162

2023

Volltextzugriff (PDF)

Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?

Journal of Crohn's and colitis, 2020-09, Vol.14 (9), p.1299-1315

2020

Volltextzugriff (PDF)

The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease

Inflammatory bowel diseases, 2016-09, Vol.22 (9), p.2112-2120

2016

Volltextzugriff (PDF)

Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy

Inflammatory bowel diseases, 2017-03, Vol.23 (3), p.448-452

2017

Volltextzugriff (PDF)

Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients

Scandinavian journal of gastroenterology, 2019-06, Vol.54 (6), p.753-760

2019

Volltextzugriff (PDF)

On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance

Current drug metabolism, 2009-11, Vol.10 (9), p.981

2009

Volltextzugriff (PDF)

Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment

Journal of Crohn's and colitis, 2012-02, Vol.6 (1), p.95-101

2012

Volltextzugriff (PDF)

Oxidation-mediated DNA crosslinking contributes to toxicity of 6-thioguanine in human cells -- letter

Cancer research (Chicago, Ill.), 2013-02, Vol.73 (4), p.1445-1445

2013

Volltextzugriff (PDF)

Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice

Journal of gastrointestinal and liver diseases : JGLD, 2010-09, Vol.19 (3), p.291

2010

Volltextzugriff (PDF)

Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis

Digestive and liver disease, 2011-02, Vol.43 (2), p.110-115

2011

Volltextzugriff (PDF)

Drug rediscovery to prevent off-label prescription reduces health care costs: the case of tioguanine in the Netherlands

Journal of gastrointestinal and liver diseases : JGLD, 2014-06, Vol.23 (2), p.123

2014

Volltextzugriff (PDF)

W1209 Azathioprine or 6-Mercaptopurine Associated Hepatotoxicity Diminishes Upon Administration of 6-Thioguanine in IBD Patients

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-674-S-674

2010

Volltextzugriff (PDF)

Allopurinol Enhances the Activity of Hypoxanthine-Guanine Phosphoribosyltransferase in Inflammatory Bowel Disease Patients During Low-Dose Thiopurine Therapy: Preliminary Data of an Ongoing Series

Nucleosides, nucleotides & nucleic acids, 2011-12, Vol.30 (12), p.1085-1090

2011

Volltextzugriff (PDF)

Tolerability and Safety of Conventional Thiopurines Concomitantly With Allopurinol in IBD-Patients With a Skewed Thiopurine Metabolism

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-771-S-771

2011

Volltextzugriff (PDF)

On the malignant potential of thiopurine therapy

Blood, 2009-06, Vol.113 (24), p.6258-6258

2009

Volltextzugriff (PDF)

W1099 Adequately Dosed 6-Thioguanine Is a Well Tolerated and Safe Rescue Drug in Azathioprine or 6-Mercaptopurine Intolerant IBD Patients

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-654-A-654

2009

Volltextzugriff (PDF)

W1110 6-Thioguanine Induces Remission and Mucosal Healing in IBD

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-656-A-656

2009

Volltextzugriff (PDF)

415 Liver Histology of IBD Patients Who are Treated With 6-Thioguanine Due to Failure of Conventional Thiopurines Reveals Very Few Cases of Nodular Regenerative Hyperplasia

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-62-S-62

2010

Volltextzugriff (PDF)

M2003 Low Inter-Observer Agreement on Nodular Regenerative Hyperplasia of the Liver: An European Inter-Observer Analysis

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-456-S-456

2010

Volltextzugriff (PDF)

ECCO consensus: evidence-based use of 6-thioguanine therapy in Crohn's disease?

Journal of Crohn's and colitis, 2010-10, Vol.4 (4), p.484-485

2010

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement

Multicentre study and systematic review: Allopurinol exposure during pregnancy

Exploring the role of oxidative stress and the effect of N‐acetylcysteine in thiopurine‐induced liver injury in inflammatory bowel disease: A randomized crossover pilot study

Therapeutic drug monitoring of methotrexate in patients with Crohn's disease

Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?

The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease

Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease

Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy

Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance

Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment

Oxidation-mediated DNA crosslinking contributes to toxicity of 6-thioguanine in human cells -- letter

Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice

Prolonged thioguanine therapy is well tolerated and safe in the treatment of ulcerative colitis

Drug rediscovery to prevent off-label prescription reduces health care costs: the case of tioguanine in the Netherlands

W1209 Azathioprine or 6-Mercaptopurine Associated Hepatotoxicity Diminishes Upon Administration of 6-Thioguanine in IBD Patients

Allopurinol Enhances the Activity of Hypoxanthine-Guanine Phosphoribosyltransferase in Inflammatory Bowel Disease Patients During Low-Dose Thiopurine Therapy: Preliminary Data of an Ongoing Series

Tolerability and Safety of Conventional Thiopurines Concomitantly With Allopurinol in IBD-Patients With a Skewed Thiopurine Metabolism

On the malignant potential of thiopurine therapy

W1099 Adequately Dosed 6-Thioguanine Is a Well Tolerated and Safe Rescue Drug in Azathioprine or 6-Mercaptopurine Intolerant IBD Patients

W1110 6-Thioguanine Induces Remission and Mucosal Healing in IBD

415 Liver Histology of IBD Patients Who are Treated With 6-Thioguanine Due to Failure of Conventional Thiopurines Reveals Very Few Cases of Nodular Regenerative Hyperplasia

M2003 Low Inter-Observer Agreement on Nodular Regenerative Hyperplasia of the Liver: An European Inter-Observer Analysis

ECCO consensus: evidence-based use of 6-thioguanine therapy in Crohn's disease?

Suchergebnisse filtern